BusinessInspirata Establishes London Office to Support Pan-European Operations for Newly Acquired Omnyx® Digital Pathology Software and its Workflow SolutionBy Nasdaq OMXApr 3, 2018, 3:25 PM UTC
BusinessNIH/NCI Grants Awarded to Inspirata and Case Western Reserve University Projects to Investigate Whole Slide Image Analysis to Predict the Aggressiveness of Certain CancersBy Nasdaq OMXMar 20, 2018, 10:00 AM UTC
BusinessInspirata’s Digital Pathology Solution Supports 1st Digital Primary Diagnosis in U.S.By Nasdaq OMXMar 19, 2018, 10:00 AM UTC
BusinessInspirata to Exhibit and Present 3 Poster Sessions at USCAP 2018 in VancouverBy Nasdaq OMXMar 16, 2018, 2:26 PM UTC
BusinessInspirata Acquires Digital Pathology Company Omnyx, Enabling Delivery of an IVD Device for Primary Diagnosis in Europe and CanadaBy Nasdaq OMXJan 31, 2018, 8:00 AM UTC
BusinessInspirata Acquires Toronto-based Artificial Intelligence In Medicine, Inc. (AIM) to Enhance its R&D in Artificial Intelligence and Natural Language ProcessingBy Nasdaq OMXJan 2, 2018, 5:00 PM UTC
BusinessInspirata Acquires Toronto-based Artificial Intelligence In Medicine, Inc. (AIM) to Enhance its R&D in Artificial Intelligence and Natural Language ProcessingBy Nasdaq OMXJan 2, 2018, 5:00 PM UTC
BusinessInspirata’s Digital Pathology Cockpit Goes Live at The Ohio State University’s James Cancer Hospital in Columbus, OhioBy Nasdaq OMXNov 7, 2017, 11:00 AM UTC
